Bio-Rad Appoints Rajat Mehta As Executive Vice President To Lead Global Commercial Strategy

Bio-Rad Laboratories has announced the appointment of Rajat Mehta as its new Executive Vice President of Global Commercial Operations, effective August 4, 2025. Mehta will be responsible for leading Bio-Rad’s global commercial strategy and execution. He succeeds Mike Crowley, who is retiring after a notable 26-year tenure with the company.

"Rajat's proven track record in delivering above-market growth, building high-achieving teams, and driving alignment across multiple business segments will be instrumental as we continue to advance our long-term strategy,” said Jon DiVincenzo, Bio-Rad’s President and Chief Operating Officer. “His focus on commercial excellence and deep understanding of large, global organizations spanning both clinical diagnostics and life science markets make him a fantastic addition to our leadership team."

Mehta brings a strong background in biopharmaceutical and diagnostics leadership. He previously served as Senior Vice President at Labcorp, overseeing extensive commercial operations in the West Division. Before that, he was Vice President and General Manager of Applied Technologies at Thermo Fisher Scientific, where he led a global business unit across diverse market segments. Mehta also held pivotal commercial roles at Dow Chemical, driving key growth initiatives.

Norman Schwartz, Bio-Rad's Chairman and CEO, added, "On behalf of everyone at Bio-Rad, I want to extend our deepest gratitude and acknowledgement to Mike Crowley for his exceptional service and unwavering dedication. Since joining our commercial team in 1998, and particularly during his tenure as EVP of Global Commercial Operations since 2014, Mike’s leadership has been instrumental in building our global sales and services organization and contributing to Bio-Rad’s overall success.”

With academic credentials that include an MBA from The Wharton School and a BS in Electrical Engineering from Kurukshetra University in India, Mehta is expected to bring strategic and operational depth to Bio-Rad's leadership team as the company strengthens its global market position in life sciences and diagnostics.